Asia Pacific Dry Eye Treatment Devices Market Size, Share & Industry Trends Analysis Report by Technology, End-user, Country and Growth Forecast, 2022-2028

The Asia Pacific Dry Eye Treatment Devices Market would witness market growth of 8.2% CAGR during the forecast period (2022-2028).

Omega-3 fatty acids are polyunsaturated fatty acids, often known as omega-3 or n-3 fatty acids (PUFAs). The family of essential oils that must obtain from food includes omega-3 fatty acids. The three most significant forms are EPA, DHA, and ALA (alpha-linolenic acid) (eicosapentaenoic acid). While DHA and EPA are primarily present in animal foods and algae, ALA is primarily found in plants.

The body needs omega-3 fatty acids to perform at its best, and they may also have a host of other potent health advantages, like enhancing heart health, lowering liver fat, promoting newborn brain development, avoiding dementia, reducing inflammation, etc. Walnuts, fish oils, chia seeds, flax seeds, fatty fish, flaxseed oil, and flaxseeds are just a few examples of foods that are frequently high in omega-3 fatty acids. An omega-3 dietary supplement, such as fish oil, is advised for persons who do not consume a lot of these foods.

It has been demonstrated that omega-3 fatty acids, such as those in fish oils and other supplements, are helpful for those with dry eyes. Meibomian Gland Dysfunction appears to be the primary cause of most dry eye conditions (MGD). When a person has MGD, the protective oil in their tears is prevented from reaching the eye's surface, which causes them to evaporate too quickly.

In China, consumer health had rapid value growth in 2018. The trend of healthy living among many customers in the nation is a major driver of the growth. Regional consumers prioritized physical health despite the fast-paced nature of modern civilization, self-medicating with OTC items from a variety of categories, including analgesics, digestive aids, cough, cold, and allergy cures, dermatological products, and sleep aids. Due to rapid growth in the demand from the working-age population disease and school/university students, dry eye treatment devices accounted for the greatest value in China's standard eye product care market.

The China market dominated the Asia Pacific Dry Eye Treatment Devices Market by Country in 2021; thereby, achieving a market value of $27.2 million by 2028. The Japan market is obtained to grow at a CAGR of 7.5% during (2022-2028). Additionally, The India market would exhibit CAGR of 8.8% during (2022-2028).

Based on Technology, the market is segmented into Meibomian Gland Expression (MGX), Broadband light (BBL), Intense Pulsed Light (IPL) and Combination (MGX+IPL). Based on End User, the market is segmented into Ophthalmic Clinics, Hospitals and Others. Based on countries, the market is segmented into China, Japan, India, Australia, South Korea, Singapore, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiBo Medical Group, Sight Sciences, Inc., Lumenis Ltd., ESW Vision SAS, Johnson & Johnson Vision Care, Inc. and Alcon, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Technology

• Meibomian Gland Expression (MGX)
• Broadband light (BBL)
• Intense Pulsed Light (IPL)
• Combination (MGX+IPL)

By End User

• Ophthalmic Clinics
• Hospitals
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Australia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• MiBo Medical Group
• Sight Sciences, Inc.
• Lumenis Ltd.
• ESW Vision SAS
• Johnson & Johnson Vision Care, Inc.
• Alcon, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free